Available online: 39.Crespo J., Lpez-Arias M.J., Iruzubieta P
In various clinical trials, doses ranging from 250 mg to 1,000 mg per day have been used without significant adverse events
It may also be recommended for individuals with a BMI of 27 or higher if they have weight-related medical conditions such as hypertension, high cholesterol, or type 2 diabetes
Research examining the overlap between anxiety and obesity found that generalized anxiety disorder shares neuroendocrine, metabolic, and behavioral pathways with excess weight
Viljoen, Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
FDA single-dose pens: one week, period Each Mounjaro or Zepbound pen contains exactly one dose